CONSUMER SAFETY ALERT

The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Official Consumer Product Safety Recall • March 18, 2020

NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.

Required Consumer Action

Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.

Contact Information

SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.

Recall Details

Sold At
Online at Amazon.com from October 2019 through February 2020 for about $25.
Injuries
None reported.
Remedy
Replace
Recall Number
20724

Product Information

Product Name
NumbSkin pain relief cream with lidocaine
Number of Units
About 8,000
Imported By
SeeNext Venture Ltd., of Blaine, Wash.
Manufactured In
Canada

Register This Product

Contact Manufacturer

Use the contact information below to reach out about this recall:

Phone 844-700-6862
Full Contact Information

SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.